| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.3 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.3 |